dopamine quinone has been researched along with alpha-synuclein in 6 studies
| Studies (dopamine quinone) | Trials (dopamine quinone) | Recent Studies (post-2010) (dopamine quinone) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 61 | 0 | 29 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, N; Machida, Y; Noda, K | 1 |
| Fujimura, T; Hattoria, N; Kubo, S; Mochizuki, H; Taka, H; Wanga, M; Yoritaka, A | 1 |
| Coleman, RA; Green, RL; Lorenz, AN; Sass, MB | 1 |
| Badillo-Ramírez, I; Rivas-Arancibia, S; Saniger, JM | 1 |
| Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y | 1 |
| Lavanya, R; Nagashanmugam, KB; Ponnusamy, S; Prabhu, N; Priyatharshni, S; Sivakumar, P | 1 |
3 review(s) available for dopamine quinone and alpha-synuclein
| Article | Year |
|---|---|
Toxic effects of dopamine metabolism in Parkinson's disease.
Topics: Aldehydes; alpha-Synuclein; Animals; Dopamine; Humans; Levodopa; Mitochondria; Oxidative Stress; Parkinson Disease | 2009 |
5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.
Topics: alpha-Synuclein; Biomarkers; Dopamine; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Humans; Metabolic Networks and Pathways; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pars Compacta; Sulfur | 2019 |
Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
Topics: alpha-Synuclein; Antioxidants; Dopamine; Humans; Parkinson Disease | 2023 |
3 other study(ies) available for dopamine quinone and alpha-synuclein
| Article | Year |
|---|---|
[Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
Topics: alpha-Synuclein; Animals; Apoptosis; Cells, Cultured; Dihydroxyphenylalanine; Dopamine; Humans; I-kappa B Proteins; Lewy Bodies; NF-KappaB Inhibitor alpha; Parkinson Disease; Phosphorylation; Ubiquitin-Protein Ligases | 2005 |
A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
Topics: alpha-Synuclein; Amyloid; Antiparkinson Agents; Computer Simulation; Dopamine; Gene Expression; Humans; Levodopa; Lewy Bodies; Lysosomes; Models, Neurological; Monoamine Oxidase Inhibitors; Neurotoxins; Parkinson Disease; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Systems Theory; Ubiquitin | 2009 |
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; alpha-Synuclein; Antioxidants; Cell Line; Copper; Dopamine; Humans; Monoamine Oxidase; Monophenol Monooxygenase; Oligodendroglia; Oxidation-Reduction; Parkinson Disease; Protein Binding; Protein Conformation; Tolcapone | 2020 |